#22 Reforming pharmacovigilance education – Michael Reumerman

Healthcare professionals are key players in medicines safety but
they often lack the time or knowledge to report adverse drug
reactions. To change that, we need to urgently rethink how we
teach pharmacovigilance, argues Michael Reumerman from Amsterdam
University Medical Centers.

Tune in to find out:


How real-life education can benefit healthcare students

Which educational intervention can be most impactful

How adverse drug event managers can improve pharmacovigilance




Want to know more?


In his PhD thesis, Michael details the current state of
pharmacovigilance education and all the real-life interventions
he and his colleagues have tested in the Netherlands so
far.

As part of an international collaboration, staff at Amsterdam UMC
have helped set up the European Open Platform for Prescribing
Education (EurOP2E), an online collection of problem-based, open
teaching resources to improve clinical pharmacology and
therapeutics education.

The World Health Organization’s Guide to Good Prescribing
provides a six-step guide for students to the process of rational
prescribing – but the time has come to update both its content
and form.

In 2018, the Netherlands Pharmacovigilance Centre Lareb developed
a core curriculum for pharmacovigilance education in
universities.

Whether you’re a healthcare professional or not, check out
Uppsala Monitoring Centre’s growing collection of self-paced
e-learning courses to learn about different aspects of
pharmacovigilance.






Join the conversation on social mediaFollow us on
Facebook, LinkedIn, X, or Bluesky and share your thoughts about
the show with the hashtag #DrugSafetyMatters.

Got a story to share?We’re always looking for new
content and interesting people to interview. If you have a great
idea for a show, get in touch!

About UMCRead more about Uppsala Monitoring Centre
and how we work to advance medicines safety.